|
Australia: Off-Patent Meds Face 23 Percent Price Cut in Spring
Australian drugmakers have agreed to a new round of market-based price cuts that will lower the cost of off-patent medicines on average 23 percent, beginning April 1.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives